{"id":"NCT02308046","sponsor":"Curatek Pharmaceuticals, LLC","briefTitle":"Multi-Center Study of New Medications to Treat Vaginal Infections","officialTitle":"Solubilized Metronidazole And/oR Terconazole Gels Intra-Vaginal Efficacy and Safety","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-06","primaryCompletion":"2017-06","completion":"2017-06","firstPosted":"2014-12-04","resultsPosted":"2020-07-27","lastUpdate":"2020-07-27"},"enrollment":212,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Vaginal Infection"],"interventions":[{"type":"DRUG","name":"Terconazole","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Terconazole vaginal gel","type":"ACTIVE_COMPARATOR"},{"label":"Gel vehicle","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the safety and efficacy of terconazole gel in the treatment of vaginal infections","primaryOutcome":{"measure":"Clinical Cure as Assessed by the Investigator at the Test-of-cure Visit","timeFrame":"7-14 days after beginning treatment","effectByArm":[{"arm":"Terconazole Vaginal Gel","deltaMin":47,"sd":null},{"arm":"Gel Vehicle","deltaMin":25,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.002"}]},"eligibility":{"minAge":"12 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":6},"locations":{"siteCount":41,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":102},"commonTop":["Bacterial vaginosis","Vulvovaginal burning sensation"]}}